Oxford Biomedica annual loss narrows; hails "commercial momentum"
(Alliance News) - Oxford BioMedica PLC on Wednesday said its client portfolio continued to expand and diversify, noting it was on track to achieve "significant" revenue growth consistent with medium-term guidance. Read More